Cutaneous hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3
|
disease |
|
Finding
|
2
|
4
|
0.600 |
moderate |
1.000 |
5 |
4
|
1996 |
2002 |
Dysganglionosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Radiation-induced xerostomia
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
2
|
1
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Carcinoma in situ of bronchus
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Medullary sponge kidney disease
|
disease |
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Stage 0 Lung Cancer AJCC v6 and v7
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Hemiparkinsonism
|
disease |
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Clear cell odontogenic carcinoma
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Impairment of attention
|
disease |
|
Mental or Behavioral Dysfunction
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Papillary ependymoma
|
disease |
Neoplasms
|
Neoplastic Process
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Neurological observations
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Hypoganglionosis
|
disease |
|
Disease or Syndrome
|
6
|
1
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Focal Neurologic Deficits
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Neurologic Dysfunction
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Gaming disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
6
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Oligodendroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Mixed Oligodendroglioma-Ependymoma
|
disease |
Neoplasms
|
Neoplastic Process
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Cellular Ependymoma
|
disease |
Neoplasms
|
Neoplastic Process
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
CCHS WITH HIRSCHSPRUNG DISEASE
|
disease |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Nervous System Diseases
|
Disease or Syndrome; Congenital Abnormality
|
7
|
1
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Neurologic Deficits
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
8
|
4
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Corneal Sensitivity
|
phenotype |
|
Sign or Symptom
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Episodic hypertension
|
phenotype |
Cardiovascular Diseases
|
Finding
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Medullary sponge kidney
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome; Congenital Abnormality
|
9
|
3
|
0.040 |
None |
1.000 |
4 |
|
2010 |
2017 |
Medullary nephrocalcinosis
|
disease |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
9
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |